期刊
INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 150, 期 1, 页码 22-27出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2010.02.022
关键词
Erythrocyte membranes; Multiple biomarkers; Cholesterol content; Coronary artery disease
Background: A new mechanism for clinical instability in coronary artery disease (CAD) has been proposed where erythrocytes could play an active role in atherosclerotic plaque growth and rupture. Clinical studies showed increased total cholesterol levels in the membrane of circulating erythrocytes (CEM) in acute coronary syndrome (ACS) patients compared to patients with chronic stable angina (CSA). We investigated the independent and incremental discriminating value of CEM along with N-terminal propeptide of BNP (NT-proBNP), high sensitivity C-reactive protein (hs CRP), myeloperoxidase (MPO) and apolipoprotein B (apoB) with regard to CAD clinical presentation. Methods: 519 consecutive angina patients were assessed; 252 had CSA (195 men, 62 +/- 9 years) and 267 had ACS (213 men, 62 +/- 10 years). CEM levels and serum concentrations of NT-proBNP, hs CRP, MPO and apoB were measured upon study admission. Results: Simple logistic regression models showed that all biomarkers could distinguish ACS, nevertheless CEM with greater potency (OR 9.26 95% CI 6.31-13.59, p<0.001). Multiple logistic regression models after adjustment for all the variables that were different between the 2 groups as well as for other biomarkers showed that CEM continued to be a significant and an independent predictor of ACS (OR 22.27 95% CI 10.63-46.67, p<0.001). An increment of the C-statistic was also shown when CEM levels were incorporated in the predictive model (including traditional vascular risk factors and new well established biomarkers i.e. hs CRP, MPO, apoB and NT-proBNP). Conclusions: The present study showed that CEM levels are associated with clinical instability in CAD patients in an independent and incremental manner. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据